8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer)
Published . Updated .
8-K - ACADIA PHARMACEUTICALS filed an 8-K with the SEC on Oct 23 (a notice of a material company event).
Directly affected
- ACAD Acadia Pharmaceuticals-29.3%
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| ACAD | +0.51% | +2.49% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-23 AccNo: 0001193125-26-430596 Size: 158 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Source: sec-edgar
Acadia Pharmaceuticals (ACAD) since “8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer),” compared with the market
| Company | When | Move | Status |
|---|---|---|---|
| Acadia Pharmaceuticals (ACAD) | three days earlier | +2.49% | final price |
| Acadia Pharmaceuticals (ACAD) | five days earlier | +0.51% | final price |
| GLD | three days earlier | +3.37% | final price |
| GLD | five days earlier | +3.56% | final price |
| QQQ | three days earlier | +2.99% | final price |
| QQQ | five days earlier | +2.00% | final price |
| SPY | three days earlier | +1.75% | final price |
| SPY | five days earlier | +0.89% | final price |
| TLT | three days earlier | -1.35% | final price |
| TLT | five days earlier | -2.31% | final price |
Who gains and who loses around Acadia Pharmaceuticals (ACAD)
Companies mentioned with this story
- ACAD Acadia Pharmaceuticals
For “8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer),” Acadia Pharmaceuticals (ACAD) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> ACAD
How “8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer)” reaches Acadia Pharmaceuticals (ACAD)
The 23 Oct 2026 story “8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer)” names Acadia Pharmaceuticals (ACAD) because of this story.
The link for Acadia Pharmaceuticals (ACAD) is this: SEC 8-K filing -> direct issuer disclosure -> ACAD
Price levels for Acadia Pharmaceuticals (ACAD)
ACAD traded between 18.40 and 28.23 across 20 sessions. The latest close on file is 19.81.
A simple score for Acadia Pharmaceuticals (ACAD)
14 out of 100
“8-K - ACADIA PHARMACEUTICALS INC (0001070494) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.